Zhejiang Qianjiang Biochemical Co., Ltd
600796.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.59 | 0.10 | 3.20 | -1.21 |
| FCF Yield | 2.21% | 0.47% | -4.20% | 2.98% |
| EV / EBITDA | 95.15 | 52.58 | 111.89 | 113.35 |
| Quality | ||||
| ROIC | 0.73% | 1.23% | 0.38% | 0.20% |
| Gross Margin | 26.90% | 28.58% | 23.18% | 20.89% |
| Cash Conversion Ratio | 4.85 | – | -2.13 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -5.92% | -5.50% | -3.69% | -4.30% |
| Free Cash Flow Growth | 437.24% | 111.59% | -222.88% | 228.27% |
| Safety | ||||
| Net Debt / EBITDA | 18.21 | 10.14 | 26.97 | 21.34 |
| Interest Coverage | 3.63 | 7.01 | 2.47 | 0.62 |
| Efficiency | ||||
| Inventory Turnover | 1.78 | 1.60 | 1.47 | 1.92 |
| Cash Conversion Cycle | 84.19 | 177.01 | 154.80 | 85.40 |